uniQure (QURE) Total Current Liabilities (2015 - 2026)
uniQure (QURE) posted quarterly Total Current Liabilities of $83.3 million for Q2 2026, up 103.63% year-over-year from $40.9 million in Q2 2025, and up 40.79% quarter-over-quarter from $59.2 million in Q1 2026.
Analysis
uniQure (QURE) Total Current Liabilities (2015 - 2026) Analysis & Trends
uniQure's Total Current Liabilities history runs 12 years deep, the most recent figure standing at $83.3 million for Q2 2026.
- In Q2 2026, Total Current Liabilities rose 103.63% year-over-year to $83.3 million; the TTM figure through Jun 2026 stood at $83.3 million (up 103.63% YoY), while the FY2025 annual figure was $62.9 million, up 57.09% from the prior year.
- Total Current Liabilities for Q2 2026 stood at $83.3 million, up from $59.2 million in the prior quarter.
- The five-year high for Total Current Liabilities was $100.6 million in Q3 2025, with the low at $36.3 million in Q1 2025.
- The 5-year median for Total Current Liabilities is $65.2 million (2022), against an average of $63.8 million.
- The sharpest annual moves came in 2022 and 2025: Total Current Liabilities jumped 106.51% in 2022, then sank 49.14% in 2025.
- uniQure's Total Current Liabilities stood at $75.9 million in 2022, then declined by 2.96% to $73.7 million in 2023, then sank by 45.64% to $40.1 million in 2024, then jumped by 57.09% to $62.9 million in 2025, then soared by 32.46% to $83.3 million in 2026.
- Business Quant data shows QURE's Total Current Liabilities at $83.3 million in Q2 2026, $59.2 million in Q1 2026, and $62.9 million in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 3.94 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 5.53 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | 1.58 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | 2.53 Bn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | 354.06 Mn |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 2.12 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 1.51 Bn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 630.93 Mn |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 438.74 Mn |
| 10 | uniQure | 2.95 Bn | 2.95 Bn | 5.49 Mn | 83.35 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 83.35 Mn |
| Mar 31, 2026 | 59.20 Mn |
| Dec 31, 2025 | 62.92 Mn |
| Sep 30, 2025 | 100.63 Mn |
| Jun 30, 2025 | 40.93 Mn |
| Mar 31, 2025 | 36.31 Mn |
| Dec 31, 2024 | 40.05 Mn |
| Sep 30, 2024 | 71.27 Mn |
| Jun 30, 2024 | 80.47 Mn |
| Mar 31, 2024 | 63.47 Mn |
| Dec 31, 2023 | 73.68 Mn |
| Sep 30, 2023 | 68.61 Mn |
| Jun 30, 2023 | 68.36 Mn |
| Mar 31, 2023 | 66.34 Mn |
| Dec 31, 2022 | 75.92 Mn |
| Sep 30, 2022 | 63.97 Mn |
| Jun 30, 2022 | 48.26 Mn |
| Mar 31, 2022 | 44.70 Mn |
| Dec 31, 2021 | 36.76 Mn |
| Sep 30, 2021 | 41.92 Mn |